Cargando…
MicroRNA-708 emerges as a potential candidate to target undruggable NRAS
RAS, the most frequently mutated oncogene that drives tumorigenesis by promoting cell proliferation, survival, and motility, has been perceived as undruggable for the past three decades. However, intense research in the past has mainly focused on KRAS mutations, and targeted therapy for NRAS mutatio...
Autores principales: | Pang, Jia Meng, Chien, Po-Chen, Kao, Ming-Chien, Chiu, Pei-Yun, Chen, Pin-Xu, Hsu, Yu-Ling, Liu, Chengyang, Liang, Xiaowei, Lin, Kai-Ti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120925/ https://www.ncbi.nlm.nih.gov/pubmed/37083947 http://dx.doi.org/10.1371/journal.pone.0284744 |
Ejemplares similares
-
Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B
por: Lin, Kai-Ti, et al.
Publicado: (2015) -
Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells
por: LEI, SAN-LIN, et al.
Publicado: (2014) -
Drugging an undruggable pocket on KRAS
por: Kessler, Dirk, et al.
Publicado: (2019) -
Therapeutic targeting of “undruggable” MYC
por: Llombart, Victor, et al.
Publicado: (2021) -
miR-708-5p: a microRNA with emerging roles in cancer
por: Monteleone, Nicholas J., et al.
Publicado: (2017)